NeuroVia NV-1205 Trial: Important News

24th September 2018

NeuroVia has informed us that they unfortunately have had to put the NV-1205 trial temporarily on hold due to issues not related to either drug or regulatory actions. They are, however, working diligently to rectify the situation as soon as possible and have asked us to share with the ALD Life community that they hope to resume the trial by the end of the year. We will keep you updated on further developments.